Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of novel celastrol-ligustrazine hybrids as potent peroxiredoxin 1 inhibitors against lung cancer
Ying Bai, Chao Liang, Jiawei Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115656-115656
Open Access | Times Cited: 9

Showing 9 citing articles:

Dual role of PRDX1 in redox-regulation and tumorigenesis: Past and future
Xin–Yuan Guan, Yiyin Ruan, Xiaoxia Che, et al.
Free Radical Biology and Medicine (2023) Vol. 210, pp. 120-129
Closed Access | Times Cited: 17
Celastrol Pyrazine Derivative Alleviates Silicosis Progression via Inducing ROS-Mediated Apoptosis in Activated Fibroblasts
Ying Bai, Chao Liang, Lu Gao, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 538-538
Open Access | Times Cited: 6
A new NCL-targeting aptamer-drug conjugate as a promising therapy against esophageal cancer
Xue Zheng, Ying Wang, Huaiyu Duan, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Ligustrazine as a multitarget scaffold in drug design and discovery
Xueyang Jiang, Siyi Li, Ning Wang, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 121, pp. 118110-118110
Closed Access
Rational design and exploitation of the molecular diversity space of PRX1‐derived SRX1 peptidic inhibitors containing proteinogenic and nonproteinogenic amino acids
Haijin Yang, Ping Li, Yi Wan, et al.
Journal of the Chinese Chemical Society (2025)
Closed Access
Integrated multi-omics analysis reveals the functional and prognostic significance of lactylation-related gene PRDX1 in breast cancer
Qinqing Wu, Heng Cao, J. Jin, et al.
Frontiers in Molecular Biosciences (2025) Vol. 12
Open Access
Peroxiredoxin-1 aggravates hypoxia-induced renal injury by promoting inflammation through the TLR4/MAPK/NF‐κB signaling pathway
Yuanyuan Han, Songkai Wang, Yiwei Xiong, et al.
Free Radical Biology and Medicine (2025)
Closed Access
Hepatocytes-derived Prdx1 regulates macrophage phenotypes via TLR4 activation in acute liver injury
Yujing Zhang, Xinru Zhang, Mingxun Zhang, et al.
International Immunopharmacology (2023) Vol. 127, pp. 111439-111439
Closed Access | Times Cited: 2
In silico analysis of small molecule compounds based on pharmacophore- and backbone-leaping peroxiredoxin 1 (PRDX1) inhibitors
Ningying Zheng, Huiting Tan, Tianli Lai, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-14
Closed Access
A detailed evaluation of the advantages among extracellular vesicles from three cell origins for targeting delivery of celastrol and treatment of glioblastoma
Xiang Zhang, Zhu Long, Zixu Qin, et al.
International Journal of Pharmaceutics (2024), pp. 125005-125005
Closed Access
Page 1

Scroll to top